This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

YRC Worldwide: Midday Volume Movers

NEW YORK ( TheStreet) -- Several small-cap stocks were moving on above-average volume during Tuesday's session.

YRC Worldwide (YRCW) continued its recent slide, falling by 25 cents, or 18.9%, to $1.07. The drop comes a day after the company launched a debt exchange offer that, if successful, will cause massive dilution of shares but will likely help the company avert bankruptcy. Volume topped 18.5 million shares, compared to the 50-day average daily volume of 10 million, according to the Nasdaq.

U.S. Energy Corp. (USEG - Get Report) jumped by 80 cents, or 15.6%, to $5.92 after Brigham Exploration (BEXP) late Monday said a BCD Farms well produced approximately 1,776 barrels of oil equivalent per day during an early 24 hour flow back period. Brigham has a participation agreement with U.S. Energy for the BCD Farms well. Volume topped 1 million shares, compared to the 50-day average daily volume of 619,000, according to the Nasdaq.

Hemispherx Biopharma (HEB - Get Report) plummeted by 24 cents, or 18%, to $1.09 after the company said it plans to complete all outstanding queries from the Food and Drug Administration regarding its application for Ampligen, an experimental therapeutic, during the final two months of 2009. Volume topped 5.6 million shares, compared to the three-month average daily volume of 4.6 million, according to Yahoo! Finance.

Chelsea Therapeutics (CHTP) fell by 64 cents, or 21.8%, to $2.30 after the company late Monday said it plans to meet with U.S. drug regulators seeking permission to change the primary endpoint of an ongoing phase III study of the droxidopa in patients with orthostatic hypotension. As a result, data from this study won't be ready for release this quarter, but will be delayed into early next year, pending the outcome of the FDA meeting, the company said. Volume topped 1.5 million shares, compared to the 50-day average daily volume of 2.3 million, according to the Nasdaq.

Carmike Cinemas (CKEC - Get Report) dropped by $2.62, or 27.4%, to $6.96 after the company late Monday swung to a third-quarter loss of $1.62 a share while revenue stayed flat in the quarter at $122.4 million. Merriman Curhan Ford downgraded the stock to neutral from buy following the report. Volume topped 200,000 shares, compared to the 50-day average daily volume of 52,000, according to the Nasdaq.

-- Written by Robert Holmes in New York.

Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CHTP $0.00 0.00%
CKEC $34.08 0.00%
HEB $0.22 0.00%
USEG $1.19 0.00%
YRCW $18.23 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs